![Kevin Lokay](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Kevin G.
Lokay worked as President & Chief Executive Officer at Jazz Pharmaceuticals (EUSA Pharma USA), Inc. from 2007 to 2008.
From 2009 to 2016, served as Vice President & Head-Business Unit at Boehringer Ingelheim Corp.
Held the position of Independent Director at Galera Therapeutics, Inc. (US) from 2019 to 2026.
Worked as Head-Change Implementation at AstraZeneca PLC from 2022 to 2023.
Education includes undergraduate studies at Lafayette College and an MBA from Purdue University.
Anciens postes connus de Kevin Lokay
| Sociétés | Poste | Fin |
|---|---|---|
| GALERA T COM USD0. | Directeur/Membre du Conseil | 03/08/2026 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/06/2023 |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets health care products | Corporate Officer/Principal | 01/12/2016 |
Jazz Pharmaceuticals (EUSA Pharma USA), Inc.
 Jazz Pharmaceuticals (EUSA Pharma USA), Inc. BiotechnologyHealth Technology Develops and markets biopharmaceutical products | Directeur Général | 01/01/2008 |
Formation de Kevin Lokay
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
63
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Jazz Pharmaceuticals (EUSA Pharma USA), Inc.
Jazz Pharmaceuticals (EUSA Pharma USA), Inc. BiotechnologyHealth Technology Develops and markets biopharmaceutical products | Health Technology |
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Galera Therapeutics, Inc.
 Galera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs to reduce normal tissue toxicity from radiotherapy | Health Technology |
Lafayette College
 Lafayette College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Purdue University
 Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets health care products | Health Technology |
